Business

10x Genomics guides higher Q4 & FY revenue than consensus (TXG:NASDAQ)

Posted by

[ad_1]

From 3rd to 4th quater symbol. Turned wooden cubes and changed words

Dzmitry Dzemidovich

  • 10x Genomics (NASDAQ:TXG) expects Q4 revenue of ~$165M, representing 9% growth Q/Q and a 10% decrease Y/Y; the figure remains above consensus estimates of $153.51M.
  • The highest Y/Y growth is estimated to come from the services segment, while the instruments

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *